Company Filing History:
Years Active: 2014-2017
Title: HsinChang Tseng: Innovator in Pharmaceutical Synthesis
Introduction
HsinChang Tseng is a notable inventor based in Tainan, Taiwan. He has made significant contributions to the field of pharmaceutical synthesis, particularly in the development of efficient methods for producing important medicinal compounds. With a total of 2 patents, Tseng's work has the potential to impact the pharmaceutical industry positively.
Latest Patents
Tseng's latest patents include a process for preparing ibrutinib and its intermediates. This invention provides efficient, economical, and improved methods for synthesizing ibrutinib, utilizing a unique biphasic acylation reaction system. This system allows for easy separation of ibrutinib from the reaction mixture without the need for additional extraction and wash steps. The isolated ibrutinib can be useful in preparing an amorphous form of the drug. Additionally, Tseng has developed a process for cabazitaxel and its intermediates, which relates to novel compounds useful in the synthesis of cabazitaxel and its analogues.
Career Highlights
HsinChang Tseng is currently associated with Scinopharm Taiwan, Ltd., where he continues to innovate in the field of pharmaceutical chemistry. His work has garnered attention for its potential to streamline the production of critical medications.
Collaborations
Tseng has collaborated with notable colleagues, including Tsung-Yu Hsiao and MengFen Ho, contributing to advancements in their shared field of expertise.
Conclusion
HsinChang Tseng's contributions to pharmaceutical synthesis through his innovative patents demonstrate his commitment to improving drug production methods. His work not only enhances efficiency but also holds promise for the future of medicinal chemistry.